Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 June 2018 Photo Supplied
Next Chapter Green Ribbon campaign addresses mental health
Members of Next Chapter and UFS Student counselling are working together to address mental health issues.

Next Chapter, a student support group at the UFS presented the Green Ribbon campaign, pledging their support to students and providing them with assistance in coping with life events that stimulate stress and contribute negatively to their mental health. The team aims to break the stigma surrounding mental health care, and continually assist students with mental health-related issues that they struggle with daily.

The Green Ribbon represents mental health awareness, which is a pressing matter for students and is the type of support students need in a stressful university environment. The campaign focuses on teaching students how to cope with life events that stimulate stress, and contribute negatively to their mental health.
 
A discussion by Dr Ancel George: practising clinical psychologist and lecturer from the UFS Department of Psychology, and Dr Mellissa Barnaschone: Director of UFS Student Counselling, took place, where talks were prominent about creating an inclusive environment for UFS students.

The panel shared a few tips on how students should work towards managing stress, and motivated them for the main mid-year examinations.
 
The follow-up Exam Cram Workshop, presented by Nadia Cloete and Lize Wolmarans, that combined time and stress management, took place on 2 June 2018, and saw students receiving advice on how to approach various issues during the examination period.
 
Mental health awareness does not end with the campaign and Next Chapter’s slogan “Your story continues” encourages students to regularly wear and commemorate the green ribbon in support of continual mental healthcare.
 
Should you have any enquiries or input for the ongoing campaign, contact the Next Chapter team on ufsnextchapter@gmail.com, or further email Tshepang Mahlatsi, founder of Next Chapter on tshepangmahlatsi767@gmail.com

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept